Loading clinical trials...
Loading clinical trials...
This clinical trial studies gallium-68 (68Ga)-prostate specific membrane antigen (PSMA) (gallium Ga 68-labeled PSMA ligand Glu-urea-Lys\[Ahx\]) positron emission tomography (PET)/computed tomography (...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Stanford University
Collaborators
NCT04550494 · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, and more
NCT04857502 · Prostate Carcinoma, Recurrent Prostate Carcinoma
NCT07073794 · Biochemically Recurrent Prostate Carcinoma, Locally Advanced Prostate Carcinoma, and more
NCT06205316 · Biochemically Recurrent Prostate Carcinoma, Oligometastatic Prostate Carcinoma, and more
NCT05054296 · Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, and more
Stanford University, School of Medicine
Palo Alto, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions